TSPAN8 and ovarian cancer: This strategy is consistent with recent data identifying Tspan8 as a blood biomarker candidate for early detection of human colon cancer [54], and demonstrating that Tspan8-specific antibodies reduce the incidence of ovarian cancer metastasis [55].